Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | 0.00% | +50.00% | 0.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Meris Kott
CEO | Chief Executive Officer | - | 17-11-29 |
Lindsey R. Perry
DFI | Director of Finance/CFO | 70 | 19-04-09 |
Monita Faris
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lindsey R. Perry
DFI | Director of Finance/CFO | 70 | 19-04-09 |
Meris Kott
CEO | Chief Executive Officer | - | 17-11-29 |
Ashleigh Vogstad
BRD | Director/Board Member | - | 19-10-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,576,471 | 48,683,850 ( 89.20 %) | 0 | 89.20 % |
Company contact information
Xtacy Therapeutics Corp.
1111 Melville Street Suite 100
V6E 3V6, Vancouver
+604-484-0355
http://globalwellnessstrategies.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.79M | |
-6.03% | 113B | |
-3.98% | 87.91B | |
+20.96% | 63.76B | |
+5.29% | 61.9B | |
+10.12% | 42.86B | |
+7.95% | 40.84B | |
+18.92% | 34.58B | |
+5.88% | 25.48B | |
-5.25% | 22.13B |
- Stock Market
- Equities
- XTCY Stock
- Company Xtacy Therapeutics Corp.